Another unknown is TaggMED with CROs. It sounds like we have deals in place waiting to be announced or finalized and announced. I doubt our revenue in that part of the TaggMED vertical would be subscriber based and more licensing revenue from the CROs and biotech companies using the tech and sending to people in the trials.